Development of laquinimod for relapsing––remitting multiple sclerosis

ISSN： 1479-6708

Source： Future Neurology, Vol.3, Iss.6, 2008-11, pp. : 641-648

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neurobiological mechanisms underlying emotional processing in relapsing-remitting multiple sclerosis

By Passamonti Luca

Brain, Vol. 132, Iss. 12, 2009-12 ,pp. : 3380-3391

Oxford University Press

Access to resources Recommend Favorite

Brain atrophy in clinically early relapsing–remitting multiple sclerosis

By Chard D.T. Griffin C.M. Parker G.J.M. Kapoor R. Thompson A.J. Miller D.H.

Brain, Vol. 125, Iss. 2, 2002-02 ,pp. : 327-337

Oxford University Press

Access to resources Recommend Favorite

Short-term brain volume change in relapsing–remitting multiple sclerosis

By Rovaris M.

Brain, Vol. 124, Iss. 9, 2001-09 ,pp. : 1803-1812

Oxford University Press

Access to resources Recommend Favorite

Cardiac repolarization during fingolimod treatment in patients with relapsing–remitting multiple sclerosis

Brain And Behavior, Vol. 8, Iss. 2, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Experimental Models of Relapsing-Remitting Multiple Sclerosis: Current Concepts and Perspective

Current Neurovascular Research, Vol. 2, Iss. 4, 2005-10 ,pp. : 349-362

Bentham Science Publishers

Access to resources Recommend Favorite